Virginia Society of Health-System Pharmacists

Latest News

  • 06/24/2020 10:00 AM | Steve Glass (Administrator)

    To:          Virginia Society of Health-System Pharmacists (VSHP)

    From:    Mark Hickman, Commonwealth Strategy Group

    Re:         Board of Pharmacy Meeting

    The Virginia Board of Pharmacy (the Board of BOP) convened a virtual meeting on June 16, 2020 (virtual meetings of government bodies during the COVID-19 public health emergency have been allowed by the Governor and General Assembly). All Board members were present.

    Licensees can obtain CE credit for participating in the Board meeting; review the agenda packet and email Board staff for more information. The agenda packet can be found here.

    Public Hearings and Adoption of Minutes

    Delivery of Dispensed Prescriptions; Labeling (pp. 10-22). A public hearing was held specifically on this matter, which was extended from previous public comment periods and Board meetings. CVS testified in support. VPhA testified in opposition. VSHP testified with the following statement: “VSHP would like the Board to consider and provide context to the various situations of alternate delivery sites and potential impact to patient safety and pharmacist-patient relationships in its decision-making on this matter.”

    The full Board meeting was then called to order, and the agenda and minutes from the previous Board meeting were approved, as amended.

    Covetrus Maine testified to reiterate their comments from the previous Board meeting in regard to Credentials for Nonresident Pharmacies Dispensing Only for Animals (see below).

    VPhA made public comment including asking that the petition to Allow Remote Order Processing by Pharmacy Technicians Outside of a Pharmacy be referred to the pharmacy technician expansion of duties work group created by HB 1304 and SB 830. VSHP concurs with that position and also testified to support the regulatory amendment that would allow for live or real-time CE credit applied for a pharmacist providing services without compensation to low income individuals receiving health services through a local health department or a free clinic, and to support the consideration to extend the timeframe for change of PIC from 14 to 30 days within the context of pharmacy acquisition.

    Board members had several questions for Natalie Nguyen, VSHP Legislative Chair, regarding the PIC transition issue. Nguyen provided answers about the application to health system pharmacies and the relevant situations and dynamics at hospitals.

    Walgreens commented on the two-year PIC requirement and change timeframe, stating that there are many factors taken into consideration when the company names a PIC (such as previous experience with the company). The two-year requirement is already a concern, and the process is an additional concern. Some locations need a PIC quickly.

    MedMen Enterprise spoke in favor of PharmaCann’s pharmaceutical processor corrective action plan. MedMen is now the owner of PharmaCann, which had obtained the provisional permit to operate in HSA III (Southwest Virginia).

    DHP Director’s Report

    Department of Health Professions (DHP) Director David Brown spoke about the recent developments on police reform and racial inequality, COVID-19 updates, and the executive actions taken to provide flexibility to the healthcare workforce to combat the pandemic in Virginia. The duration of pharmacy related waivers during the emergency declaration is under discussion by staff, who are considering recommending their effect through the end of this calendar year, but need to discuss with the Board Chairman.

    Legislative/Regulatory/Guidance

    Update on Regulatory/Policy Actions Resulting from 2020 General Assembly and the Report of Regulatory Actions (pp. 23-26). Elaine Yeatts, DHP Senior Policy Analyst, noted that the pharmacist scope protocols are to be adopted at the September Board meeting, and that the brown/white bagging proposed final regulations are now at the office of the Secretary of Health and Human Resources for review. Recall that the Board accepted VSHP’s comments requesting an exemption of the proposed regulations on brown/white bagging for patients receiving hemophilia treatment.

    Adopt Exempt Regulations for Pharmaceutical Processors (pp. 27-69). These proposed actions are exempted from the regular rulemaking process in order to expedite conforming regulations to current law, primarily to update the definition of CBD/THC-A oil to cannabis oil as passed in legislation this year – Adopted.

    Consider Petition for Rulemaking to Amend 18VAC110-20-276 to Allow Remote Order Processing by Pharmacy Technicians Outside of a Pharmacy (pp. 70-80). A letter from NACDS seeking additional modifications, beyond the submitted petition, to pharmacy technician duties was displayed on the screen for the Board to read and will be made available to the public electronically. The practice requested in the petition is happening now under emergency COVID-19 waivers. The pharmacy technician expansion of duties work group will not meet until 2021. The Board voted to deny the petition and refer the matter to the Regulation Committee.

    Consider Adoption of Fast-track Regulation to Allow Volunteer CE to Satisfy Live CE Requirement (pp. 81-83). Staff recommended adding new language to allow for a maximum of 2 hours of delivery of volunteer pharmacy services in accordance with current regulations, for a total of 6 hours of volunteer CE – Adopted.

    Adoption of Emergency Regulations for Limited-Use License and Permit for Non-Profit Facilities (pp. 84-89) – The Board discussed the definition of “non-profit” and the potential use of a limited-use license and permit by different kinds of non-profits. The Board voted to defer adoption and request that counsel and staff conduct additional research for presentation at the next Board meeting.

    Adopt Guidance Document 110-49 Credentials for Nonresident Pharmacies Dispensing Only for Animals (pp. 90-92) – Approved.

    Adopt Guidance Document 110-48 Verification Sources for a Pharmaceutical Processor (pp. 93-96). In addition to the proposed document, the Board voted to change the definition of CBD/THC-A oil to conform to the new definition of “cannabis oil” (referenced above) to be consistent with other document references – Approved.

    Adopt draft Guidance Document for use of telemedicine by registered practitioners of cannabis oil (this proposed document was not included in the board agenda packet and will be made available to the public electronically). The document complies with federal telemedicine guidelines as mandated by state law, requiring secure two-way audio-visual interaction – Approved.

    Amend Guidance Documents 110-4, 110-8, 110-9, 110-16, 110-20, 110-22, 110-27, 110-35 (pp. 97-151). These updates are a result of periodic review and contain technical and “clean-up” updates and references – Approved in a block except for 110-4 (see below).

    Guidance Document 110-4 was discussed separately as staff provided an updated version regarding CE, which will be made available electronically – Approved as amended.

    Repeal Guidance Documents 110-14, 110-19, 110-32, and 110-40 (pp. 152-158). References in these Guidance Documents are now in law or regulation, which make the documents no longer necessary – Approved.

    Request to Amend Guidance Document 110-39 Guidance for Continuous Hours Worked by Pharmacists and Breaks (pp. 159-160). The Board has received complaints of confusion and conflicts when a pharmacist is on break but the pharmacy is still open to patients, so the pharmacist often does not have an uninterrupted break. The Board discussed patient access vs. pharmacist wellness and patient safety. The Board voted to refer the matter to the Regulation Committee.

    Request for Guidance for Granting Exception to Minimum Two Years’ Experience for PIC Eligibility (pp. 161-163). The Board discussed that various factors are taken into consideration when authority is delegated to the Executive Director (ED) and Board Chairman to ensure safety and operational continuity. A motion was made to accept the proposed guidance for due process and delegate authority to the ED and Chairman to grant exceptions, consistent with Board bylaws (staff to develop final language) – Adopted.

    Request to Amend Regulation to Extend Change of PIC Timeframe from 14 to 30 Days (pp. 164-166). The Board had discussion around the need for PIC to PIC transition, PIC training, periodic inventory timeline, and needs in various contexts and settings. A few members proposed 21 instead of 30 days. The Board voted to refer the matter to the Regulation Committee.

    Consideration for Requiring CE on a Specific Topic in 2021 (pp. 167-168). The Board discussed various possible topics but decided to defer to next year.

    Verbal Update on Action Item from December 2019 Board Meeting regarding Virginia Immunization Information System. Staff reached out to the Virginia Department of Health (VDH) and wrote an article that was included in the March licensee newsletter. Any future COVID-19 vaccination will be required to be reported. Registration in the information system is encouraged now.

    Election of Chairman and Vice Chairman. The Board elected Kris Ratliff as Chairman and Cheryl Nelson as Vice Chairman.

    Chairman’s Report. Chairman Warriner expressed her thanks and farewell as she completes her final term on the Board.

    Report on Board of Health Professions. The BHP meeting was canceled so no report.

    Reports on Licensure Program (pp. 170) and Inspection Program (pp. 171-181). Refer to the reports provided in the agenda packet.

    Report on Pharmaceutical Processors (p. 182). Columbia Care in Portsmouth and Green Leaf Medical in Richmond have been awarded final permits. Dharma in Bristol has underdone inspection. 2500 patients have registered.

    Report on Disciplinary Program (pp. 183-209). Disciplinary proceedings were suspended in March, April and May due to the COVID-19 public health emergency. A large backlog of cases is expected when proceedings resume.

    Executive Director’s Report (p. 210). Caroline Juran stated that if the Governor does not make timely Board appointments, Warriner and Thornbury, who are completing their 8-year terms, may need to continue to serve until replacements are appointed. Juran said she has been invited to give a presentation on July 7, 2020 to a legislative committee on drug pricing.

    Review of the inspection report for PharmaCann’s pharmaceutical processor location, PharmaCann’s submitted corrective action plan, and PharmaCann’s application for a pharmaceutical processor permit (p. 169). The Board went into closed session to discuss this matter. When it came out of close session, the Board reported that PharmaCann has 90 days to correct their inspection, and that the Board will be issuing an RFA for the license.

    ADA examination accommodation requests – After going into closed session, the Board reported that all requests were approved.

    The next Board meeting is scheduled for September 9, 2020 at 9:00AM. The next Regulation Committee meeting is scheduled for November 12, 2020 at 9:00AM.

  • 06/22/2020 9:19 AM | Steve Glass (Administrator)

     

    Greetings, VSHP members!

    As my year as VSHP President comes to a close, I would like to thank you all for allowing me to represent our organization. VSHP advocated with a strong voice at the state and national level for a number of important issues this year, including expanding pharmacist and pharmacy technician scope of practice, enhancing pharmacy technician training, as well as taking a patient-centric stance on drug importation and disposal. I have been proud to sign as the representative of our membership to support these issues and I am proud of the progress we’re making and the results we’ve achieved.

    The past few months have presented a multitude of unexpected challenges for health system pharmacy. VSHP remains committed to supporting our members – from providing resources for managing COVID-19 responses, to hosting a residency platform presentation program, as well as developing a number of virtual continuing education webinars, VSHP is encouraging our members to continue learning and collaborating in a time of social distancing. Given the dynamic situation regarding group gatherings, VSHP is also developing strategies and contingency plans to ensure we will continue providing value to our membership, but we’re definitely looking forward to when we can all come together again in person to collaborate and network with our colleagues.

    I’d like to close by thanking all the outgoing VSHP Board members for their service, and welcoming the incoming Board members to their roles. Additionally, I’d like to recognize and thank all the committee chairs and our executive director Steve Glass for their efforts over the past year, and in particular send a big thank you to Cindy Williams for her leadership and support of all things VSHP as she finishes her three years on the Executive Board. A volunteer organization like ours gains its strength from its volunteers, and VSHP is privileged to have so many members willing to sacrifice their time to support the mission of educating, advocating, and collaborating across the Commonwealth. If you would like to expand your involvement with VSHP, please consider joining a committee, becoming a mentor, submitting an education session proposal, applying for a grant, donating to the PAC, or running for the Board of Directors next year – participation in VSHP has been the most enriching time I’ve spent in my professional life, and I believe it will be for you as well!

     

    Cheers,

    Scott Anderson

    VSHP Immediate Past-President

  • 06/15/2020 3:25 PM | Steve Glass (Administrator)

    FREE CE for VSHP Members! 

    Webinar-Wednesday, July 1, 2020 – 12:00pm- 1:00 pm

    One hour of live CE.  This is an encore presentation from the Spring Seminar

    Title:  Trauma Drama: Traversing Tranexamic Acid Use in the Trauma Population

     

    Presenter:

    Donna Shuler Truoccolo, PharmD, BCPS, NHDP-BC

     

    Learning Objectives-Pharmacists:

    ·         Describe how the mechanism of action of tranexamic acid relates to the needs of the general trauma population

    ·         Interpret the key clinical trials available describing the use of tranexamic acid in trauma patients

    ·         Examine literature supporting the use of alternate routes of tranexamic acid in trauma patients

    ·         Evaluate a patient case in order to design an appropriate treatment plan using tranexamic acid in a bleeding trauma patient

    Learning Objectives-Pharmacy Technicians

    ·         Describe how the mechanism of action of tranexamic acid relates to the needs of the general trauma population

    ·         List the key clinical trials available describing the use of tranexamic acid in trauma patients

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 1 days after the event and no later than 60 days after the event.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. 

    UAN # 0108-0000-20-041-L01-P; 0108-0000-20-041-L01-T

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    Members:
    To register:  https://us02web.zoom.us/webinar/register/WN_zJGRBzsXRPSslS8k9M2Eag

     

    After registering, you will receive a confirmation email containing information about joining the webinar.

  • 06/15/2020 2:37 PM | Steve Glass (Administrator)

    3rd Annual VSHP Residency Forum. 

    This year's forum will be held virtually on Friday, July 24, 2020 from 1p-4p.

    The forum is open to active VSHP members at no cost.  Last year, over 50% of the residents in Virginia attended the forum.  Residency Program Directors are also invited to attend. 

    Tentative Agenda:

    o   Welcome and VSHP Discussion- Matt Jenkins, Current VSHP President

    o   Keynote- Janet Silvester

    o   Financial Planning- Jonathan Lafrenaye

    o   IRB Overview- Kathy Koehl

    o   Time Management

    Please share the attached information with your incoming residents and other members of your team.  We hope to see you there.

    To register for the Residency Forum

    To join VSHP

  • 06/11/2020 5:24 PM | Steve Glass (Administrator)

    The agenda for the June 16th Full Board Meeting is now posted, and can be found at the link below.

     

    https://townhall.virginia.gov/L/ViewMeeting.cfm?meetingid=30066  

  • 06/06/2020 8:51 AM | Steve Glass (Administrator)

    ASHP's new COVID Care Certified course prepares pharmacists and pharmacy technicians for managing clinical and operational challenges during the pandemic. The self-paced, online course includes a variety of relevant, evidence-based resources and tools to care for patients in all stages of COVID-19, including those critically ill. It also addresses managing pharmacy staffing and workflow, as well as supply chain challenges.  CE credit is available for selected activities. 

    After completion, participants will receive documentation that they are COVID Care Certified by ASHP; documentation is good for 3 years.  

    This course is free for ASHP members, with reduced rates for institutions and others.  It is available by visiting:

    https://store.ashp.org/Store/ProductListing/ProductDetails.aspx?productId=745207963

  • 06/06/2020 8:50 AM | Steve Glass (Administrator)

    Additional Guidance on Transferring Medications to Mitigate Diversion

    VSHP clarified with the BOP regarding this situation. Please see below:

    If a pharmacy is in need of transferring drugs to another pharmacy to mitigate possible diversion due to emergency circumstances, it may transfer the drugs via invoice under the current waiver of the 5% allowance for a pharmacy to act as a wholesale distributor without holding a license as a wholesale distributor. 

    • Schedule II drugs must be transferred via DEA 222 form. 
    • A common carrier or pharmacist should perform the movement of the drugs. 
    • Any transfer of these drugs back to the original pharmacy location must also be done via invoice and DEA 222 form, as necessary. 
    • Pharmacies should alert the Board and the DEA local field office of this transfer.   

    DEA is finalizing guidance on this subject as well and hopes to post the information later today on its website. 

    The board will email licensees additional guidance after seeing DEA’s position in hopes of creating consistency.


    Below is copied from https://www.dhp.virginia.gov/Pharmacy/news/PharmacyCoronavirusInfoUpdate05042020.pdf

    New as of 4/28/2020: 5% Distribution Rule (§ 54.1-3435.02(A))
    Notwithstanding Virginia Code § 54.1-3435.02(A), a permitted pharmacy that fully complies with all other requirements of 21 CFR 1307.11 may distribute controlled substances beyond five percent of the gross annual sales of prescription drugs by the relevant permitted pharmacy or beyond five percent of the total dosage units of the Schedule II through V controlled substances dispensed annually by the relevant permitted pharmacy without being licensed as a wholesale distributor. This exception is in effect until the public health emergency declared by the Governor in EO51 expires or is terminated, unless the Board of Pharmacy specifies an earlier date or otherwise first modifies or withdraws this exception. All distributions made by a permitted pharmacy from January 1, 2020, until the date this exception ends will be excluded from consideration in applying the five percent wholesale distribution restrictions in § 54.1-3435.02(A).

    Natalie Nguyen, PharmD, MSHA

    VSHP Legislative Committee Chair
  • 06/06/2020 8:29 AM | Steve Glass (Administrator)

    FREE CE for VSHP Members! 

    Webinar-Thursday, June 11, 2020 – 7:00pm- 8:00 pm

    One hour of live CE

    Sponsored by VSHP Region 2

    Title:  Drug Allergy:  A Review of Antimicrobial Induced Hypersensitivities

     

    Presenter:

    Memar Ayalew, Pharm.D.

    ASP/ID Clinical Pharmacy Specialist

    Walter Reed National Military Medical Center Bethesda, MD

     

    Learning Objectives:

    ·         Describe the impact of penicillin allergies on stewardship

    ·         Classify types of drug hypersensitivity reactions

    ·         Recognize clinical manifestations and onset of immunological mediated drug reactions

    ·         Review strategies for management of penicillin allergy

    ·         Discuss induction of drug tolerance and graded challenge procedures

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 1 days after the event and no later than 60 days after the event.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. 

    UAN # 0108-0000-20-038-L01-P; 0108-0000-20-038-L01-T

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    Members:
    To register:  https://us02web.zoom.us/webinar/register/WN_w91xM260RXGmW7I5emL1iw

    After registering, you will receive a confirmation email containing information about joining the webinar.

  • 05/28/2020 11:27 AM | Steve Glass (Administrator)

    FREE CE for VSHP Members! 

    Webinar-Wednesday, June 3, 2020 – 7:00pm- 8:00 pm

    One hour of live CE

    Sponsored by VSHP Region 2

    Title:  Optimizing Medication Safety Among Culturally Diverse Patients

     

    Presenter:

    Nkem Nonyel, Pharm.D., MPH, BCPS

    Assistant Professor of Pharmacy Practice

    UMES School of Pharmacy

     

    Learning Objectives:

    • ·         Explain at least two medication safety issues among culturally diverse patient populations.
    • ·         Describe at least two strategies for promoting medication safety among patients form diverse cultural backgrounds.
    • ·         Given a case scenario with patient-related cultural variables, provide patient education to optimize medication safety.-Characterize postpartum depression and its impact

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 1 days after the event and no later than 60 days after the event.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. 

    UAN # 0108-0000-20-030-L05-P; 0108-0000-20-030-L05-T

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    Members:
    To register:  https://us02web.zoom.us/webinar/register/WN_4kmnB6JESbyN4fgGAWdDLg

     


    After registering, you will receive a confirmation email containing information about joining the webinar.

  • 05/26/2020 1:09 PM | Steve Glass (Administrator)

    VSHP is a member-driven organization and as such our success is dependent on meeting the diverse needs of our colleagues practicing in various settings across the state. The VSHP Board of Directors would like to solicit your ideas and opinions on current programming offered by VSHP as well as identify new opportunities to enhance the organization’s value to our membership.   

    Below is a link to a member survey which is designed to help us better understand your needs.  Please visit the link below.

    https://www.surveymonkey.com/r/L7SXJY2

    Please take a few minutes of your time to provide us with this important input.  

    We kindly request your response by  June 5, 2020.   The first 50 members to complete the survey will be entered into a drawing for a $25 Amazon gift card.

    Thank you for your participation and your support of VSHP

VSHP Members,

As healthcare providers, we are essential personnel on the front lines of the nation and state response to the COVID-19 pandemic.  In an effort to keep our members up-to-date, we have compiled the information below.  Recent information includes:

Sterile Compounding Resources

1.  Critical Point hosted a webinar on March 18th.  The link to a recorded version and the slides will be available on Critical Point website later today or tomorrow.  Also, you can register, for no charge, as a silver member of Critical Point in order to get access to additional tools.

https://www.criticalpoint.info/

 

2.  USP published guidelines today related to re-use of garb used in sterile compounding during COVID-19 pandemic.  It can be found at https://www.usp.org/sites/default/files/usp/document/about/public-policy/usp-covid19-garb-and-ppe.pdf

 

3.  USP has also published guidelines related to pharmacy compounding of hand sanitizer.

https://www.usp.org/sites/default/files/usp/document/about/public-policy/usp-covid19-handrub.pdf

 

4. ASHP Planning Resources:

ASHP has developed a checklist that can be utilized to assist health system pharmacy departments and leaders in comprehensive planning.  https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP_COVID19_AssessmentTool.ashx?la=en&hash=D4222461335FCEAB8DE30F996388232700B9543F

 

ASHP has also made their COVID-19 resources available to non-members.

 

5.In response to Governor Northam’s declared state of emergency in Executive Order Number Fifty-One (2020) regarding COVID-19 and as authorized in §54.1-3307.3 of the Code of Virginia, the Virginia Board of Pharmacy has approved emergency provisions for the duration of the declared emergency.  https://www.dhp.virginia.gov/Pharmacy/news/PharmacyCoronavirusInformation3-13-2020.pdf

 

Please let us know additional resources that would be beneficial as we work together to continue to support our communities as essential healthcare personnel.

 

Thank you,

VSHP Executive Committee

3/18/2020

Virginia Board of Pharmacy

Important COVID-19 Information


In response to Governor Northam’s declared state of emergency in Executive Order Number Fifty-One (2020) regarding COVID-19 and as authorized in §54.1-3307.3 of the Code of Virginia, the Virginia Board of Pharmacy has approved emergency provisions for the duration of the declared emergency.  Click here to access the information.

Questions may be directed to pharmbd@dhp.virginia.gov.

3/16/2020

VSHP participates in ASHP Comments to CMS Regarding Scope of Practice

ASHP, in collaboration with other national pharmacy groups and their affiliates including VSHP, has submitted extensive recommendations to CMS regarding the elimination of regulations that limit pharmacists from practicing at the top of their license. CMS requested additional input and recommendations under the Oct. 3, 2019, Executive Order “Protecting and Improving Medicare for Our Nation’s Seniors.”

1/25/2020

Contacts

contact@vshp.org

tel:  850-906-0779

fax:  850-893-1845

Copyright© 2020, Virginia Society of Health-System Pharmacists. All rights reserved.                                                                                                 

Powered by Wild Apricot Membership Software